High Tech Pharm Co., Ltd. (KOSDAQ:106190)
South Korea · Delayed Price · Currency is KRW 15,420
-480 (-3.02%)
At close: Mar 19, 2026
High Tech Pharm Market Cap
High Tech Pharm has a market cap or net worth of 205.65 billion as of March 20, 2026. Its market cap has increased by 30.41% in one year.
Market Cap
205.65B
Enterprise Value
191.25B
Revenue
70.18B
Ranking
n/a
PE Ratio
17.92
Stock Price
15,420.00
Market Cap Chart
Since July 28, 2010, High Tech Pharm's market cap has increased from 96.60B to 205.65B, an increase of 112.88%. That is a compound annual growth rate of 4.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 205.65B | 60.90% |
| Dec 30, 2025 | 127.81B | -14.14% |
| Dec 30, 2024 | 148.86B | 50.05% |
| Dec 28, 2023 | 99.21B | 28.39% |
| Dec 29, 2022 | 77.27B | -20.44% |
| Dec 30, 2021 | 97.12B | -25.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 237.74B |
| GREEN CROSS WellBeing | 182.42B |
| OPTUS Pharmaceutical | 181.76B |
| Organoidsciences | 172.88B |
| Vivozon Pharmaceutical | 170.70B |
| Kyung Dong Pharmaceutical | 146.56B |
| DongKoo Bio & Pharma | 141.97B |
| PHARMARESEARCH BIO | 138.17B |